These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Extracellular Nucleotide Hydrolysis in Dermal and Limbal Mesenchymal Stem Cells: A Source of Adenosine Production. Naasani LIS; Rodrigues C; de Campos RP; Beckenkamp LR; Iser IC; Bertoni APS; Wink MR J Cell Biochem; 2017 Aug; 118(8):2430-2442. PubMed ID: 28120532 [TBL] [Abstract][Full Text] [Related]
6. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. Volonté C; D'Ambrosi N FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212 [TBL] [Abstract][Full Text] [Related]
7. History of ectonucleotidases and their role in purinergic signaling. Zimmermann H Biochem Pharmacol; 2021 May; 187():114322. PubMed ID: 33161020 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cells Ageing: Targeting the "Purinome" to Promote Osteogenic Differentiation and Bone Repair. Noronha-Matos JB; Correia-de-Sá P J Cell Physiol; 2016 Sep; 231(9):1852-61. PubMed ID: 26754327 [TBL] [Abstract][Full Text] [Related]
9. The roles of purinergic signaling in psychiatric disorders. Cieślak M; Czarnecka J; Roszek K Acta Biochim Pol; 2016; 63(1):1-9. PubMed ID: 26495439 [TBL] [Abstract][Full Text] [Related]
10. [The role of ectonucleotides metabolizing enzymes in purinergic signaling]. Porowińska D; Czarnecka J; Komoszyński M Postepy Biochem; 2011; 57(3):294-303. PubMed ID: 22235655 [TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA. Volonté C; Parisi C; Burnstock G CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):751-67. PubMed ID: 22963439 [TBL] [Abstract][Full Text] [Related]
12. Neurogenic Differentiation of Mesenchymal Stem Cells Induces Alterations in Extracellular Nucleotides Metabolism. Czarnecka J; Porowińska D; Bajek A; Hołysz M; Roszek K J Cell Biochem; 2017 Mar; 118(3):478-486. PubMed ID: 27472650 [TBL] [Abstract][Full Text] [Related]
13. Pathological roles of purinergic signaling in the liver. Vaughn BP; Robson SC; Burnstock G J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619 [TBL] [Abstract][Full Text] [Related]
14. Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Cavaliere F; Donno C; D'Ambrosi N Front Cell Neurosci; 2015; 9():211. PubMed ID: 26082684 [TBL] [Abstract][Full Text] [Related]
16. The trophic effects of purines and purinergic signaling in pathologic reactions of astrocytes. Rathbone MP; Middlemiss P; Andrew C; Caciagli F; Ciccarelli R; Di Iorio P; Huang R Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S36-45. PubMed ID: 9769028 [TBL] [Abstract][Full Text] [Related]
17. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. Yegutkin GG Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535 [TBL] [Abstract][Full Text] [Related]
18. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. Gharibi B; Abraham AA; Ham J; Evans BA J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734 [TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis. Lu D; Insel PA Am J Physiol Cell Physiol; 2014 May; 306(9):C779-88. PubMed ID: 24352335 [TBL] [Abstract][Full Text] [Related]